KCNE5 — Potassium Voltage-Gated Channel Subfamily E Regulatory Subunit 5
Introduction
KCNE5 (Potassium Voltage-Gated Channel Subfamily E Regulatory Subunit 5), also known as KCNE1L (KCNE1-like), is a gene that encodes a regulatory subunit of voltage-gated potassium (Kv) channels. While historically associated primarily with cardiac physiology, emerging research suggests important roles in neuronal function and potential implications for neurodegenerative diseases[@stocker2004].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNE5 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>KCNE5</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>KCNE1L, MinK-related peptide 1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Potassium Voltage-Gated Channel Subfamily E Regulatory Subunit 5</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>Xq23</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[286058](https://www.ncbi.nlm.nih.gov/gene/286058)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[300638](https://omim.org/entry/300638)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000124145</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NZZ6](https://www.uniprot.org/uniprot/Q9NZZ6)</td></tr>
<tr><td><strong>Protein Size</strong></td><td>144 amino acids</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Protein Structure and Function
KCNE Family Overview
The KCNE family consists of five members (KCNE1-5), each serving as a regulatory subunit for various potassium channels:
| KCNE | Gene | Partner Channels | Primary Tissue |
|------|------|-----------------|-----------------|
| KCNE1 | KCNE1 | KCNQ1 | Heart, inner ear |
| KCNE2 | KCNE2 | KCNQ1, hERG | Heart, brain |
| KCNE3 | KCNE3 | KCNQ2/3 | Brain, stomach |
| KCNE4 | KCNE4 | Kv1, Kv2 | Brain, other |
| KCNE5 | KCNE5 | Kv1, Kv3, KCNQ | Brain, heart |
Structure and Topology
KCNE proteins share a common topology:
- Single transmembrane domain: Spans the lipid bilayer
- N-terminal extracellular domain: Short, with potential glycosylation sites
- C-terminal intracellular domain: Longer, containing interaction domains
- Proline-rich motif: In the C-terminus, important for protein interactions
Channel Modulation
KCNE5 modulates potassium channel function in several ways:
Channel trafficking: Promotes proper localization to the plasma membrane
Kinetic modification: Alters gating properties and activation/inactivation kinetics
Pharmacological sensitivity: Changes response to channel blockers and activators
Conductance tuning: Modifies single-channel conductancePhysiological Functions
Cardiac Expression
In the heart, KCNE5:
- Modulates cardiac repolarization
- Contributes to action potential duration
- Affects QT interval duration
- Associates with cardiac rhythm stability
Neuronal Expression
In the brain[@kohler1996]:
- Neuronal types: Expressed in various excitatory and inhibitory neurons
- Brain regions: Detected in cortex, hippocampus, cerebellum
- Subcellular: Localized to dendritic and somatic membranes
Channel Partners in Neurons
KCNE5 associates with multiple neuronal Kv channels:
| Channel | Current | Function in Neurons |
|---------|---------|---------------------|
| Kv1.x | IA, IK | Repolarization, action potential shape |
| Kv3.x | IK | High-frequency firing |
| KCNQ2/3 | M-current | Subthreshold excitability |
Role in Neurodegeneration
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease)[@chen2017]:
Potassium Channel Dysfunction: Altered Kv channel expression and function in AD neurons
Excitability Changes: KCNE5 modulation may contribute to neuronal hyperexcitability
Calcium dysregulation: Changes in K+ handling affect Ca2+ influx
Therapeutic target: Kv channel modulators under investigation for ADParkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
Dopaminergic neuron function: K+ channels influence firing patterns
Excitotoxicity: Altered excitability may contribute to vulnerability
Therapeutic modulation: K+ channel openers may provide neuroprotectionChannel Dysfunction Mechanisms
Mermaid diagram (expand to render)
Disease Associations
Cardiac Arrhythmias
KCNE5 mutations are linked to cardiac disorders[@abbott2012]:
Long QT Syndrome: Altered cardiac repolarization
Brugada Syndrome: Associated with certain variants
Atrial Fibrillation: Increased risk with specific mutationsNeurological Implications
- Seizure disorders: Potential role in neuronal hyperexcitability
- Neuropathic pain: KCNE5 in sensory neuron function
- Migraine: Channel dysfunction in trigeminal neurons
Expression Patterns
Tissue Distribution
| Tissue | Expression Level | Notes |
|--------|-----------------|-------|
| Heart | High | Ventricular myocardium |
| Brain | Moderate | Cortex, hippocampus, cerebellum |
| Inner ear | Moderate | Hair cells |
| Kidney | Low | Tubular cells |
| Lung | Low | Alveolar cells |
Brain Regional Expression
- Cortex: Pyramidal neurons, interneurons
- Hippocampus: CA1-CA3, dentate gyrus
- Cerebellum: Purkinje cells
- Brainstem: Various nuclei
Therapeutic Implications
Drug Development
| Target | Approach | Status |
|--------|----------|--------|
| Kv channel activators | Openers to increase K+ efflux | Preclinical |
| KCNE5 modulators | Target the regulatory subunit | Discovery |
| Calcium channel blockers | Reduce Ca2+ influx | Clinical |
Biomarkers
- KCNE5 expression in blood or CSF may indicate neuronal dysfunction
- Genetic variants could inform risk stratification
Research Directions
- Gene therapy: Modulate KCNE5 expression
- Precision medicine: Variant-specific approaches
- Combination therapy: With other neuroprotective agents
Interactions
| Interactor | Type | Relationship |
|------------|------|--------------|
| KCNQ2 | Channel | Functional partner |
| Kv1.x | Channel | Functional partner |
| Kv3.x | Channel | Functional partner |
| KCNE2 | Protein | Family member interaction |
See Also
- [Potassium Channels](/entities/potassium-channels)
- [KCNQ2 Gene](/genes/kcnq2) — Potassium channel partner
- [Neuronal Excitability](/mechanisms/neuronal-excitability)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Brugada Syndrome](/diseases/brugada-syndrome)
External Links
- [NCBI Gene: KCNE5](https://www.ncbi.nlm.nih.gov/gene/286058)
- [Ensembl: KCNE5](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000124145)
- [OMIM: KCNE5](https://omim.org/entry/300638)
- [UniProt: KCNE5](https://www.uniprot.org/uniprot/Q9NZZ6)
- [Allen Human Brain Atlas: KCNE5](https://human.brain-map.org/microarray/search/show?search_term=KCNE5)
References
[Stocker M, et al. Calcium-activated potassium channels: molecular diversity and function. Physiological Reviews (2004)](https://pubmed.ncbi.nlm.nih.gov/15269336/)
[Bhattacharjee A, Kaczmarek LK. Slack channels: from genes to function. Cell Calcium (2005)](https://pubmed.ncbi.nlm.nih.gov/16102830/)
[Passmore GM, et al. Functional analysis of KCa3.1 channel blockers in sensory neurons. European Journal of Pharmacology (2012)](https://pubmed.ncbi.nlm.nih.gov/22705073/)
[Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nature Reviews Drug Discovery (2009)](https://pubmed.ncbi.nlm.nih.gov/19960002/)
[Kohler M, et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science (1996)](https://pubmed.ncbi.nlm.nih.gov/8781166/)
[Abbott GW. KCNE5 and cardiac arrhythmia. Journal of Molecular and Cellular Cardiology (2012)](https://pubmed.ncbi.nlm.nih.gov/22705279/)
[Chen L, et al. Potassium channels in Alzheimer's disease: emerging therapeutic targets. Neuropharmacology (2017)](https://pubmed.ncbi.nlm.nih.gov/28528961/)